Related Experiment Video
Updated: May 30, 2026
05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Staged single-ventricle palliation in 2011: outcomes and expectations
1Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, USA. petit@bcm.edu
Congenital Heart Disease
|August 10, 2011
Summary
Outcomes for single-ventricle heart disease have improved, but patients still face numerous interventions and complications. The Fontan operation, while separating blood flow, carries significant long-term risks for these patients.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Surgical Outcomes
Background:
- Outcomes for single-ventricle heart disease (SVHD) have improved significantly over 20 years.
- Improved survival has led to higher parental expectations for quality of life.
- Despite advances, SVHD patients undergo numerous interventions and experience high complication rates.
Purpose of the Study:
- To review the outcomes of single-ventricle heart disease patients.
- To discuss the history and evolution of current treatment strategies.
- To highlight recent studies and ongoing challenges in Fontan patient care.
Main Methods:
- Review of historical data and outcomes for SVHD.
- Analysis of the total cavopulmonary connection (Fontan operation) effectiveness and costs.
- Synthesis of recent clinical studies and research findings.
Main Results:
- Staged palliation for SVHD has shown improved survival rates.
- The Fontan operation, while achieving hemodynamic separation, incurs significant risks.
- Fontan patients remain at high risk for complications despite "favorable" hemodynamics.
Conclusions:
- Continued vigilance and research are necessary for managing Fontan patients.
- Addressing the high complication burden is crucial for improving long-term quality of life.
- Further studies are needed to refine strategies and mitigate risks in SVHD management.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...